Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin) for Treatment of Brain Metastasis.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Bevacizumab (Primary)
- Indications Brain metastases; Breast cancer; Solid tumours
- Focus Adverse reactions
- Acronyms REBECA
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Feb 2013 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History